Aldeyra Therapeutics Inc to Discuss the Results from the SOLACE Trial in Noninfectious Anterior Uveitis Call

25/6/2019 8:00

שיחת ועידה Aldeyra Therapeutics Inc

Aldeyra Therapeutics Inc Conference call or earnings call will be held on 25/06/2019 via an 800 number (toll-free). During the earnings conference call's session Aldeyra Therapeutics Inc will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conferencing dial conference bridge and key in the PIN code, Contact Aldeyra Therapeutics Inc for this information
Schedule a teleconference with QCONF and get 5 free calls with our conference service.
We are a biotechnology company focused primarily on the development of new products for diseases caused by inflammation and inborn errors of metabolism that are thought to be related to naturally occurring toxic and pro-inflammatory chemical species known as aldehydes. We have developed a series of aldehyde traps, molecules that are designed specifically to sequester and allow for the degradation of aldehydes.    
קרא עוד שיחת ועידה

Aldeyra Therapeutics Inc (ALDX)

131 Hartwell Avenue, Lexington Massachusetts 02421, United States